Polfarmex S.A.

Poland

All drugs from this manufacturer

  • ADEKSA

    The medicine is used in the treatment of type 2 diabetes (insulin-dependent), especially in overweight individuals for whom diet and exercise alone have not yielded sufficient results.

    Dosage form: tablets

    Active substance Dosage
    acarbose 50 mg

    ATC: A10BF01

  • The medicine is used in the treatment of type 2 diabetes (insulin-dependent), especially in overweight individuals for whom diet and physical activity alone have not yielded sufficient results.

    Dosage form: tablets

    Active substance Dosage
    acarbose 100 mg

    ATC: A10BF01

  • The medicine is used to reduce the level of uric acid in the body. It is indicated, among other things, for the treatment of gout, kidney stones, and in conditions where there is a risk of their occurrence, e.g., during the treatment of certain cancers.

    Dosage form: tablets

    Active substance Dosage
    allopurinol 100 mg

    ATC: M04AA01

  • The medicine is used to reduce the level of uric acid in the body. It is indicated, among others, for the treatment of gout, kidney stones, and in conditions where there is a risk of their occurrence (e.g., during the treatment of certain cancers).

    Dosage form: tablets

    Active substance Dosage
    allopurinol 300 mg

    ATC: M04AA01

  • The medicine is used for the temporary and short-term relief of symptoms of the common cold, influenza, flu-like illnesses, and paranasal sinusitis. It helps with fever, runny nose, cough, headache, sore throat, as well as muscle and joint pain.

    Dosage form: tablets, film-coated

    Active substance Dosage
    paracetamol 325 mg
    pseudoephedrine hydrochloride 30 mg
    dextromethorphan hydrobromide 10 mg

    ATC: N02BE51

  • It is used as an adjunct therapy in individuals with reduced immunity during recurrent upper respiratory tract infections and in the treatment of herpes of the lips and facial skin.

    Dosage form: tablets

    Active substance Dosage
    inosine pranobex 500 mg

    ATC: J05AX05

  • It is used in the treatment of arterial hypertension, stable angina pectoris, and vasospastic angina pectoris (Prinzmetal's angina).

    Dosage form: tablets

    Active substance Dosage
    amlodipine besylate 10 mg

    ATC: C08CA01

  • It is used in the treatment of arterial hypertension and stable and vasospastic angina pectoris (Prinzmetal's angina).

    Dosage form: tablets

    Active substance Dosage
    amlodipine besylate 5 mg

    ATC: C08CA01

  • The medicine is intended for the treatment of high blood pressure (hypertension) and stable coronary artery disease.

    Dosage form: tablets

    Active substance Dosage
    perindopril arginine 5 mg
    amlodipine 5 mg

    ATC: C09BB04

  • The medicine is intended for the treatment of high blood pressure (hypertension) and stable coronary artery disease.

    Dosage form: tablets

    Active substance Dosage
    perindopril arginine 10 mg
    amlodipine 5 mg

    ATC: C09BB04

  • The medicine is intended for the treatment of high blood pressure (hypertension) and stable coronary artery disease.

    Dosage form: tablets

    Active substance Dosage
    perindopril arginine 10 mg
    amlodipine 10 mg

    ATC: C09BB04

  • It is used in the treatment of generalized anxiety disorders and disorders occurring in somatic form (i.e., physical discomfort not directly related to organ disease). It exhibits anxiolytic and calming effects and mildly improves mood.

    Dosage form: tablets, film-coated

    Active substance Dosage
    opipramol dihydrochloride 50 mg

    ATC: N06AA05

  • It is used for the symptomatic treatment of runny nose and nasal congestion resulting from a cold, influenza, or allergic rhinitis and sinusitis.

    Dosage form: tablets, film-coated

    Active substance Dosage
    pseudoephedrine hydrochloride 60 mg

    ATC: R01BA02

  • The medicine is used for the temporary relief of symptoms of nasal and paranasal sinus congestion, accompanied by headache, sinus pain, and fever during influenza or the common cold.

    Dosage form: tablets, film-coated

    Active substance Dosage
    ibuprofen 200 mg
    pseudoephedrine hydrochloride 30 mg

    ATC: M01AE51

  • Asaris is used to prevent breathing disorders occurring in asthma and chronic obstructive pulmonary disease (COPD). In the case of COPD, it helps to reduce the number of symptom exacerbations.

    Dosage form: powder for inhalation

    Active substance Dosage
    fluticasone propionate 0.1 mg
    salmeterol 0.05 mg

    ATC: R03AK06

  • The medicine is used to prevent breathing disorders occurring in asthma and chronic obstructive pulmonary disease (COPD). The 500 μg + 50 μg dose also helps to reduce the number of COPD symptom exacerbations.

    Dosage form: powder for inhalation

    Active substance Dosage
    fluticasone propionate 0.25 mg
    salmeterol 0.05 mg

    ATC: R03AK06

  • The medicine is used to prevent breathing disorders occurring in asthma and chronic obstructive pulmonary disease (COPD). In the case of COPD, it also helps to reduce the number of symptom exacerbations.

    Dosage form: powder for inhalation

    Active substance Dosage
    fluticasone propionate 0.5 mg
    salmeterol 0.05 mg

    ATC: R03AK06

  • The medicine is used to prevent breathing difficulties caused by asthma (including exercise-induced or nocturnal asthma) and in chronic obstructive pulmonary disease (COPD). It also helps to relieve an attack of shortness of breath or wheezing in the airways, although it does not act immediately.

    Dosage form: powder for inhalation, divided

    Active substance Dosage
    salmeterol xinafoate 50 mcg

    ATC: R03AC12

  • The medicine is used to facilitate expectoration by reducing the viscosity of secretions. It is recommended for acute and chronic diseases of the upper respiratory tract, bronchi, and lungs, as well as for preventing seasonal exacerbations of chronic bronchitis.

    Dosage form: tablets

    Active substance Dosage
    erdosteine 300 mg

    ATC: R05CB15

  • It is used as an adjunct in the treatment of mild to moderate chronic asthma in individuals over 15 years of age. It also helps to prevent exercise-induced bronchospasm and relieves symptoms of seasonal allergies (hay fever).

    Dosage form: tablets, film-coated

    Active substance Dosage
    montelukast sodium 10 mg

    ATC: R03DC03

  • It is used as an adjunct in the treatment of mild to moderate chronic asthma in children aged 2 to 5 years. It also helps to prevent airway constriction primarily induced by physical exertion in children over 2 years of age.

    Dosage form: tablets, chewable

    Active substance Dosage
    sodium montelukast 4 mg

    ATC: R03DC03

  • The medicine helps to relieve the symptoms of chronic asthma (mild or moderate) in children aged 6 to 14 years and prevents airway constriction mainly induced by physical exertion.

    Dosage form: tablets, chewable

    Active substance Dosage
    sodium montelukast 5 mg

    ATC: R03DC03

  • The medicine is used for the treatment and prevention of recurrence of edema (fluid retention in tissues or body cavities) associated with heart failure, and for the treatment of primary arterial hypertension.

    Dosage form: tablets

    Active substance Dosage
    torasemide 5 mg

    ATC: C03CA04

  • It is used for the treatment and prevention of recurrence of edema (fluid retention in tissues or body cavities) that may result from heart failure.

    Dosage form: tablets

    Active substance Dosage
    torasemide 10 mg

    ATC: C03CA04

  • The medicine is used to treat and prevent the recurrence of edema (fluid retention in tissues or body cavities) that may result from heart failure.

    Dosage form: tablets

    Active substance Dosage
    torasemide 20 mg

    ATC: C03CA04

  • The medicinal product is used for the symptomatic treatment of cough of various origins.

    Dosage form: syrup

    Active substance Dosage
    butamirate citrate 0.15 mg

    ATC: R05DB13

  • It is used in the treatment of high blood pressure and symptomatic heart failure in adults.

    Dosage form: tablets, film-coated

    Active substance Dosage
    valsartan 80 mg

    ATC: C09CA03

  • The medicine is used to treat high blood pressure and symptomatic heart failure in adults.

    Dosage form: tablets, film-coated

    Active substance Dosage
    valsartan 160 mg

    ATC: C09CA03

  • The medicine is used to treat loss of appetite (anorexia) or weight loss resulting from cancer or acquired immunodeficiency syndrome (AIDS).

    Dosage form: suspension, oral

    Active substance Dosage
    megestrol acetate No input provided

    ATC: L02AB01

  • The medicinal product is used to supplement calcium deficiencies in the body and for the prevention and treatment of the consequences of these deficiencies.

    Dosage form: syrup

    Active substance Dosage
    calcium gluconate 29.4 mg/100 ml
    calcium lactobionate 6.4 mg/100 ml

    ATC: A12AA20

  • The medicine is used to treat arterial hypertension, chronic heart failure, diabetic nephropathy, and in patients following a myocardial infarction with left ventricular dysfunction.

    Dosage form: tablets

    Active substance Dosage
    captopril 25 mg

    ATC: C09AA01

  • The medicine is intended for the treatment of arterial hypertension, chronic heart failure, diabetic nephropathy, and asymptomatic left ventricular dysfunction following myocardial infarction.

    Dosage form: tablets

    Active substance Dosage
    captopril 50 mg

    ATC: C09AA01

  • The medicine is used to treat arterial hypertension, chronic heart failure, diabetic nephropathy, and in patients following a myocardial infarction with left ventricular dysfunction.

    Dosage form: tablets

    Active substance Dosage
    captopril 12.5 mg

    ATC: C09AA01

  • The medicine is intended for the treatment of arterial hypertension and chronic heart failure.

    Dosage form: tablets, film-coated

    Active substance Dosage
    cilazapril 1 mg

    ATC: C09AA08

  • The medicine is used in the treatment of arterial hypertension and chronic heart failure.

    Dosage form: tablets, film-coated

    Active substance Dosage
    cilazapril 2.5 mg

    ATC: C09AA08

  • The medicine is intended for the treatment of arterial hypertension and chronic heart failure.

    Dosage form: tablets, film-coated

    Active substance Dosage
    cilazapril 5 mg

    ATC: C09AA08

  • The medicine is used to treat acute attacks of gout to reduce inflammation. It also helps to prevent acute gout attacks when used alongside other medications that lower uric acid levels.

    Dosage form: tablets, film-coated

    Active substance Dosage
    colchicine 0.5 mg

    ATC: M04AC01

  • The medicinal product is used for the treatment of symptoms of endometriosis (to reduce its lesions) and for the symptomatic treatment of severe pain and tenderness in the case of fibrocystic mammary dysplasia.

    Dosage form: tablets

    Active substance Dosage
    danazol 200 mg

    ATC: G03XA01

  • It is a diuretic used in the treatment of essential hypertension. It may be used alone or in combination with other blood pressure medications.

    Dosage form: tablets, film-coated, prolonged release

    Active substance Dosage
    indapamide 1.5 mg

    ATC: C03BA11

  • The medicine is used to treat many infections caused by bacteria and protozoa, including respiratory tract infections (e.g., pneumonia, sinusitis), urinary tract infections, sexually transmitted diseases (e.g., chlamydiosis), gastrointestinal infections (e.g., cholera, traveler's diarrhea), Lyme disease, malaria, as well as eye and soft tissue infections.

    Dosage form: capsules, hard

    Active substance Dosage
    doxycycline 100 mg

    ATC: J01AA02

  • The medicine is used as a supportive treatment in individuals with reduced immunity experiencing recurrent upper respiratory tract infections, and in the treatment of herpes of the lips and facial skin caused by the herpes simplex virus.

    Dosage form: tablets

    Active substance Dosage
    inosine pranobex 500 mg

    ATC: J05AX05

  • It is used as an adjunct therapy in individuals with reduced immunity experiencing recurrent upper respiratory tract infections, and in the treatment of herpes of the lips and facial skin (in individuals previously diagnosed with herpes simplex virus infection).

    Dosage form: syrup

    Active substance Dosage
    inosine pranobex 500 mg/5 ml

    ATC: J05AX05

  • It is used as a supportive treatment in individuals with reduced immunity during recurrent upper respiratory tract infections and in the treatment of herpes of the lips and facial skin (in individuals previously diagnosed with herpes simplex virus infection).

    Dosage form: tablets

    Active substance Dosage
    inosine pranobex 1000 mg

    ATC: J05AX05

  • It is used to treat fungal skin infections (e.g., groin, feet, or hairy scalp) and nail fungus caused by dermatophytes. However, it is not effective in treating pityriasis versicolor.

    Dosage form: tablets

    Active substance Dosage
    terbinafine hydrochloride 281.3 mg

    ATC: D01BA02

  • The medicine is used for the short-term and occasional treatment of sleep disorders, such as difficulty falling asleep, frequent nighttime awakenings, or waking up too early in the morning.

    Dosage form: tablets

    Active substance Dosage
    estazolam 2 mg

    ATC: N05CD04

  • The medicine is used to treat infections caused by pathogenic fungi (e.g., Candida yeasts, fungal infections of the skin, nails, or genital organs) and to prevent these infections.

    Dosage form: syrup

    Active substance Dosage
    fluconazole 0.5 g

    ATC: J02AC01

  • The medicine is used to treat fungal infections (e.g., skin, nail, genital, or oral and throat mucosal infections) and to prevent recurrences of certain infections or to prevent new infections in individuals with a weakened immune system.

    Dosage form: tablets

    Active substance Dosage
    fluconazole 50 mg

    ATC: J02AC01

  • It is used to treat infections caused by fungi (e.g., Candida yeasts), such as fungal infections of the skin, nails, genitals, or the mucous membranes of the mouth and throat. It may also be used to prevent recurrences of certain infections or to prevent infections in individuals with a weakened immune system.

    Dosage form: tablets

    Active substance Dosage
    fluconazole 150 mg

    ATC: J02AC01

  • The medicinal product is used for the treatment of fungal infections (e.g., skin, nail, genital, or oral and throat mucosal infections) and for the prevention of yeast infections.

    Dosage form: tablets

    Active substance Dosage
    fluconazole 100 mg

    ATC: J02AC01

  • The medicinal product is used to treat infections caused by pathogenic fungi (e.g., Candida yeasts) and to prevent these infections. It may be used for infections of the mucous membranes, genital organs, skin, and nails, as well as for meningitis.

    Dosage form: tablets

    Active substance Dosage
    fluconazole 200 mg

    ATC: J02AC01